Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients

Background: Psychiatric patients are at risk of cardiovascular diseases, and many psychotropic drugs can prolong QTc interval. Requirements for electrocardiogram (ECG) monitoring have been set up in our psychiatric university hospital. The objective of this study was to determine the proportion of a...

Full description

Bibliographic Details
Main Authors: Nicolas Ansermot, Meredith Bochatay, Jürg Schläpfer, Mehdi Gholam, Ariane Gonthier, Philippe Conus, Chin B Eap
Format: Article
Language:English
Published: SAGE Publishing 2019-12-01
Series:Therapeutic Advances in Psychopharmacology
Online Access:https://doi.org/10.1177/2045125319891386
_version_ 1811223740322676736
author Nicolas Ansermot
Meredith Bochatay
Jürg Schläpfer
Mehdi Gholam
Ariane Gonthier
Philippe Conus
Chin B Eap
author_facet Nicolas Ansermot
Meredith Bochatay
Jürg Schläpfer
Mehdi Gholam
Ariane Gonthier
Philippe Conus
Chin B Eap
author_sort Nicolas Ansermot
collection DOAJ
description Background: Psychiatric patients are at risk of cardiovascular diseases, and many psychotropic drugs can prolong QTc interval. Requirements for electrocardiogram (ECG) monitoring have been set up in our psychiatric university hospital. The objective of this study was to determine the proportion of adult patients who had an ECG during their hospitalization, the prevalence of ECG abnormalities, the evolution of the QTc after admission, and the risk factors for QTc prolongation. Methods: Retrospective analysis of ECGs and clinical data of all patients with a complete hospitalization in 2015. Assessment of the influence of covariates on QTc using linear mixed-effects models. Results: At least one ECG ( n  = 600) was performed during 37.6% of the stays ( n  = 1198) and in 45.5% of the patients ( n  = 871). Among the patients with an ECG, 17.9% had significant ECG abnormalities, including 7.6% with a prolonged QTc. QTc measured at admission and during hospitalization did not change significantly ( n  = 46, 419.4 ± 29.7 ms, 417.2 ± 27.6 ms, p  = 0.71). In the multivariate model (292 patients, 357 ECGs), the covariates significantly associated with the QTc were gender (+15.9 ms if female, p  < 0.0001), age (+0.4 ms/year, p  = 0.0001), triglyceride levels (+5.7 ms/mmol/l, p  = 0.005), and drugs with known risk of torsades de pointes (+6.2 ms if ⩾1 drug, p  = 0.028). Conclusions: The prevalence of hospitalized psychiatric patients with an abnormal ECG indicates that ECGs should be performed systematically in this population. Prescription of psychotropic drugs should be done cautiously, particularly in patients with QTc prolongation risk factors.
first_indexed 2024-04-12T08:37:29Z
format Article
id doaj.art-78d1bc9fe8b14a288f2bbfee951e6513
institution Directory Open Access Journal
issn 2045-1261
language English
last_indexed 2024-04-12T08:37:29Z
publishDate 2019-12-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Psychopharmacology
spelling doaj.art-78d1bc9fe8b14a288f2bbfee951e65132022-12-22T03:39:59ZengSAGE PublishingTherapeutic Advances in Psychopharmacology2045-12612019-12-01910.1177/2045125319891386Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patientsNicolas AnsermotMeredith BochatayJürg SchläpferMehdi GholamAriane GonthierPhilippe ConusChin B EapBackground: Psychiatric patients are at risk of cardiovascular diseases, and many psychotropic drugs can prolong QTc interval. Requirements for electrocardiogram (ECG) monitoring have been set up in our psychiatric university hospital. The objective of this study was to determine the proportion of adult patients who had an ECG during their hospitalization, the prevalence of ECG abnormalities, the evolution of the QTc after admission, and the risk factors for QTc prolongation. Methods: Retrospective analysis of ECGs and clinical data of all patients with a complete hospitalization in 2015. Assessment of the influence of covariates on QTc using linear mixed-effects models. Results: At least one ECG ( n  = 600) was performed during 37.6% of the stays ( n  = 1198) and in 45.5% of the patients ( n  = 871). Among the patients with an ECG, 17.9% had significant ECG abnormalities, including 7.6% with a prolonged QTc. QTc measured at admission and during hospitalization did not change significantly ( n  = 46, 419.4 ± 29.7 ms, 417.2 ± 27.6 ms, p  = 0.71). In the multivariate model (292 patients, 357 ECGs), the covariates significantly associated with the QTc were gender (+15.9 ms if female, p  < 0.0001), age (+0.4 ms/year, p  = 0.0001), triglyceride levels (+5.7 ms/mmol/l, p  = 0.005), and drugs with known risk of torsades de pointes (+6.2 ms if ⩾1 drug, p  = 0.028). Conclusions: The prevalence of hospitalized psychiatric patients with an abnormal ECG indicates that ECGs should be performed systematically in this population. Prescription of psychotropic drugs should be done cautiously, particularly in patients with QTc prolongation risk factors.https://doi.org/10.1177/2045125319891386
spellingShingle Nicolas Ansermot
Meredith Bochatay
Jürg Schläpfer
Mehdi Gholam
Ariane Gonthier
Philippe Conus
Chin B Eap
Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
Therapeutic Advances in Psychopharmacology
title Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
title_full Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
title_fullStr Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
title_full_unstemmed Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
title_short Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
title_sort prevalence of ecg abnormalities and risk factors for qtc interval prolongation in hospitalized psychiatric patients
url https://doi.org/10.1177/2045125319891386
work_keys_str_mv AT nicolasansermot prevalenceofecgabnormalitiesandriskfactorsforqtcintervalprolongationinhospitalizedpsychiatricpatients
AT meredithbochatay prevalenceofecgabnormalitiesandriskfactorsforqtcintervalprolongationinhospitalizedpsychiatricpatients
AT jurgschlapfer prevalenceofecgabnormalitiesandriskfactorsforqtcintervalprolongationinhospitalizedpsychiatricpatients
AT mehdigholam prevalenceofecgabnormalitiesandriskfactorsforqtcintervalprolongationinhospitalizedpsychiatricpatients
AT arianegonthier prevalenceofecgabnormalitiesandriskfactorsforqtcintervalprolongationinhospitalizedpsychiatricpatients
AT philippeconus prevalenceofecgabnormalitiesandriskfactorsforqtcintervalprolongationinhospitalizedpsychiatricpatients
AT chinbeap prevalenceofecgabnormalitiesandriskfactorsforqtcintervalprolongationinhospitalizedpsychiatricpatients